Investing-News.Com
Information for Investors

MERCK CO INC, (MRK) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

MERCK CO INC, (MRK) Stock Rating Learn More

Our Overall Rating on Merck & Co Inc,  MRK is BUY
StockPickReport.Com research suggests MRK's price will move significantly higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

Both stochastic and "relative strength" indicators point to a move up.

Investors, traders, and other market participants may find this a good opportunity to buy MRK, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains.

Trading volume seems to be falling and MRK's closing price moved up during the week before this rating was initiated.

Our BUY Rating on MRK was issued on 03/25/08

MERCK CO INC Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces MERCK CO INC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in MERCK CO INC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on MERCK CO INC. This software is specially designed to give precision entry and exit points on MERCK CO INC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When MERCK CO INC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even MERCK CO INC, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: joseph ferona  yasmine el rashidi wsj  eog stock sell volume 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Final Glance: Pharmaceuticals companies (AP)

Midday Glance: Pharmaceuticals companies (AP)

Early Glance: Pharmaceuticals companies (AP)

InPlay: Merck: New study shows that JANUVIA significantly reduced blood sugar levels and was not associated with hypoglycemia in elderly patients with type 2 diabetes (Briefing.com)

New Study Data: JANUVIA (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes (Business Wire)

Obama's Pick for Attorney General Has Experience on Corporate Crime (at The Wall Street Journal Online)

Final Glance: Pharmaceuticals companies (AP)

Will Waxman, the New Boss, Be the Same as the Old Boss? (at The Wall Street Journal Online)

Merck Offering To Help Patients-Or Itself? (at CNBC)

US doctors to be on guard for meningitis in kids (at Reuters)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.